Clinical Trials Directory

Trials / Completed

CompletedNCT04608279

Urinary Creatinin/Protein Ratio in Preterms

Evolution of the Proteinuria / Creatininuria Ratio in the First Month of Life in the Preterm Infant

Status
Completed
Phase
Study type
Observational
Enrollment
124 (actual)
Sponsor
Centre Hospitalier Universitaire de la Réunion · Academic / Other
Sex
All
Age
1 Day – 2 Days
Healthy volunteers
Not accepted

Summary

From the first days of life, the newborn presents a "physiological" proteinuria explained by the coexistence of a glomerular and tubular immaturity, all the more marked as the gestational age (GA) is weak. In the child term, proteinuria decreases the first month and its persistence is the marker of kidney damage. The persistence of proteinuria in preterm infants is also considered a marker of renal impairment; however, neither the "physiological" values nor the pattern of urinary excretion of proteins in the first month of life are known. The proteinuria / creatininuria ratio is a validated indicator of proteinuria, as it is correlated with 24-hour urine proteinuria.

Conditions

Timeline

Start date
2017-01-01
Primary completion
2020-01-01
Completion
2020-01-01
First posted
2020-10-29
Last updated
2020-10-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04608279. Inclusion in this directory is not an endorsement.

Urinary Creatinin/Protein Ratio in Preterms (NCT04608279) · Clinical Trials Directory